Healthcare Nova

The only information source for private healthcare services in Emerging Markets, click here to download a brochure

HealthcareNova - : White Paper

Interview: Ian Wootton, London-based head of healthcare corporate banking at Japan’s largest bank

How do the big banks decide to lend – and how do they view the healthcare market? We speak with Ian Wootton, EMEA head of healthcare corporate banking division at Japan’s largest bank,... [+]

Interview: Frederic Llordachs, CEO of review and booking site Doctoralia

Doctoralia, the Spanish-based online healthcare appointment booking and review site with a strong presence in Latin America merged with its Polish-based competitor DocPlanner last year. Healthcare Europa talks to Doctoralia CEO Frederic Llordachs about business models, the merger, and the future of booking sites.

Intermedica tight lipped about plans to sell, IPO – or both

Intermedica, the private Brazilian payor-provider headquartered in Sao Paulo, Brazil, is refusing to comment on its prospective stock market flotation or sale - telling Healthcare Nova that, at this stage, it is “not allowed to comment on anything to do with IPOs or strategy”. But according to one sources in Brazil, Intermedica may go for a mix of both IPO and sale.

Interview: Fadil Elamin, Founder, Khartoum Dentist, Sudan

Sudan is open for business. And those willing to take the risk of entering a previously sieged economy, may find themselves turning over more than $32m a year, just like Fadil Elamin who runs Khartoum Dentist, a growing chain of dental clinics in the capita

Egyptian efforts to engage foreign patients

Egypt, despite a rocky socio-political past, is being touted by the government as a venue for medical tourism. Healthcare Nova speaks to Ghada Ganzouri, board member and head of business development at Ganzouri Specialised Hospital (GSH) in Cairo, about the country's potential to become an international medical hub.

Stent price cap hurts Indian groups

Margins at Indian hospital groups are under pressure after the National Pharmaceutical Pricing Authority (NPPA) fixed the prices of stents last month, says Navneet Bali, COO of International Oncology Group Services.